1. Home
  2. EXPI vs EVO Comparison

EXPI vs EVO Comparison

Compare EXPI & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eXp World Holdings Inc.

EXPI

eXp World Holdings Inc.

HOLD

Current Price

$6.76

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.78

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPI
EVO
Founded
2008
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
934.1M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
EXPI
EVO
Price
$6.76
$2.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$9.75
$7.00
AVG Volume (30 Days)
870.8K
91.4K
Earning Date
05-11-2026
04-08-2026
Dividend Yield
3.18%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$500,147,681.00
N/A
Revenue This Year
$6.26
$1.37
Revenue Next Year
$5.50
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
220.39
N/A
52 Week Low
$5.66
$2.31
52 Week High
$12.23
$4.80

Technical Indicators

Market Signals
Indicator
EXPI
EVO
Relative Strength Index (RSI) 60.03 45.59
Support Level $5.68 $2.63
Resistance Level $6.87 $3.78
Average True Range (ATR) 0.23 0.09
MACD 0.04 -0.04
Stochastic Oscillator 81.56 31.23

Price Performance

Historical Comparison
EXPI
EVO

About EXPI eXp World Holdings Inc.

eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: